Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: The HIV outpatient study (HOPS)

Annals of Epidemiology

Volumn 9, Issue 6, 1999, Pages 349-357

  Moorman, Anne C ^a   Holmberg, Scott D ^a   Marlowe, Steven I ^b   Von Bargen, Jennifer C ^a   Yangco, Bienvenido G ^c   Palella, Frank J ^d   Ward, Douglas J ⁱ   Loveless, Mark O ^e   Fuhrer, Jack ^f   Joseph, Patrick ⁱ   Alexander, William A ^g   Aschman, Diane J ^h  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b West Paces Medical Center   (United States)

^c INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Oregon Health and Sciences University   (United States)

^f STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^g Southside Healthcare   (United States)

^h Hlth Res Netwk Apache Med Syst   (United States)

ⁱ NONE

Author keywords

AIDS; Epidemiology; Health care utilization; HIV; Opportunistic infection

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ATOVAQUONE; AZITHROMYCIN; CD4 ANTIGEN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CLOTRIMAZOLE; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; FOSCARNET SODIUM; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENTAMIDINE; PRIMAQUINE; PROTEINASE INHIBITOR; RIFABUTIN; RIFAMPICIN; STAVUDINE; TETRACYCLINE DERIVATIVE; TRIMETREXATE; VANCOMYCIN; ZALCITABINE; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; COUGHING; DEPRESSION; DIARRHEA; DYSPNEA; FATIGUE; FEMALE; FEVER; HEALTH CARE UTILIZATION; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFORMATION PROCESSING; KAPOSI SARCOMA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTICENTER STUDY; MYALGIA; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICIAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RETINITIS; RISK ASSESSMENT; SLEEP DISORDER; SORE THROAT; SWEATING; VISUAL DISORDER; VOMITING; WASTING SYNDROME;

ADULT; AMBULATORY CARE; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; TREATMENT OUTCOME; UNITED STATES;

EID: 0033179077     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00005-8     Document Type: Article

References (27)

1. Farizo K.M., Buehler J.W., Chamberland M.E., Whyte B.M., Sivarajan Froelicher E., Hopkins S.G.et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 267:1992;1798-1805.
2. Greenberg A.E., Thomas P.A., Landesmann S.H., Mildvan D., Seidlin M., Friedland G.H.et al. The spectrum of HIV-1-related disease among outpatients in New York City. AIDS. 6:1992;849-859.
3. Lubeck D.P., Bennett C.L., Mazonson P.D., Fifer S.K., Fries J.F. Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr. 6:1993;478-484.
4. Holmberg S.D., Buchbinder S.P., Conley L.J., Wong L.C., Katz M.H., Penley K.A.et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol. 141:1995;395-404.
5. Melnick S.L., Sherer R., Louis T.A., Hillman D., Rodriguez E.M., Lackman C.et al. Survival and disease progression according to gender of patients with HIV infection. JAMA. 272:1994;1915-1921.
6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1997;8(2):10-12.
7. Kitahata M.M., Koepsell T.D., Deyo R.A., Maxwell C.L., Dodge W.T., Wagner E.H. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 334:1996;701-706.
8. Moorman A.C., Von Bargen J.C., Palella F.J., Holmberg S.D., the HOPS Investigators Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. J Acquir Immune Defic Syndr. 19:1998;182-188.
9. Von Bargen J.C., Moorman A.C., Holmberg S.D. How many pills do patients with HIV infection take? [letter]. JAMA. 280:1998;29.
10. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A.et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 338:1998;853-860.
11. Hirschtick R.E., Glassroth J.E., Jordan M.C., Wilcosky T.C., Wallace J.M., Kvale P.A.et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 333:1995;845-851.
12. Holmberg S.D., Moorman A.C., Von Bargen J.C., Palella F.J., Loveless M.O., Ward D.J., Navin T.R., HOPS Investigators Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. JAMA. 279:1998;384-386.
13. Loveless M, Delaney K, Moorman A, McCabe R, the HOPS Investigators. Quantification of pain syndromes in the HIV Outpatient Study (HOPS). Presented at the 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC; January 1997.
14. Hoover D.R., Saah A.J., Bacellar H., Phair J., Detels R., Anderson R.et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med. 329:1993;1922-1926.
15. Katz M.H., Hessol N.A., Buchbinder S.P., Hirozawa A., O'Malley P., Holmberg S.D. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis. 170:1994;198-202.
16. 3. J Infect Dis. 170:1994;1284-1287.
17. Peters B.S., Beck E.J., Coleman D.G., Wadsworth M.J.H., McGuiness O., Harris J.R.W.et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom. the changing face of AIDS BMJ. 302:1991;203-207.
18. Selik R.M., Chu S.Y., Ward J.W. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med. 23:1995;933-936.
19. Conley L.J., Bush T.J., Buchbinder S.P., Penley K.A., Judson F.N., Holmberg S.D. The association of cigarette smoking with selected HIV-related medical conditions. AIDS. 10:1996;1121-1126.
20. Burns D.N., Hillman D., Neaton J.D., Sherer R., Mitchell T., Capps L.et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. J AIDS. 13:1996;374-383.
21. Saah A.J., Hoover D.R., Peng Y., Phair J.P., Visscher B., Kingsley L.A.et al. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA. 273:1995;1197-1202.
22. Aschman D, Fuhrer J, Moorman A, Pathak D, the HOPS Investigators. Resource utilization in HIV patients diagnosed with CMV. Presented at the 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC; January 1997.
23. Chaisson MA, Berenson L, Li W, Schwartz S, Mojica B, Hamburg M. Declining AIDS mortality in New York City (NYC). Presented at the 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC; January 1997.
24. Mouton Y, Cartier F, Dellamonica P, Humbert G, Lang JM, Massip P, et al. Dramatic cut in AIDS defining events and hospitalization for patients under protease inhibitors (P.I) and tritherapies (TTT) in 9 AIDS reference centers (ARC) and 7,391 patients. Presented at the 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC; January 1997.
25. Torres R.A., Barr M. Impact of combination therapy for HIV infection on inpatient census [letter]. N Engl J Med. 336:1997;1531-1532.
26. Hogg R.S., O'Shaughnessy M.V., Gataric N., Yip B., Craib K., Schechter M.T.et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet. 349:1997;1294.
27. Michaels S.H., Clark R., Kissinger P. Declining morbidity and mortality among patients wiht advanced human immunodeficiency virus infection [letter]. N Engl J Med. 339:1998;405-406.